BBH News and Press, VanEck Vectors Biotech ETF From 11/22/25

2025-11-22 00:30:00 ET By Kristy Akullian, CFA Fundamentals In Focus 1. This earnings season mattered more than most. Read the full article on Seeking Alpha For further details see: Q3 Earnings Beat Expectations Amid Signs Of AI Fatigue

2025-11-21 11:15:29 ET More on markets Dividend Roundup: Nvidia, Home Depot, Nike, Johnson & Johnson, and more U.S. growth is set to reaccelerate in 2026, Apollo’s Slok notes Nasdaq and SGX forge a pathway for seamless U.S.–Singapore dual listings ...

2025-11-18 11:25:00 ET More on markets UBS shrugs off high valuations as it focuses on strong earnings Cantor Fitzgerald says current de-risking clears a runway for a year-end rally 2 Events Could Make Me Buy More Than Ever Commodities And The Next Major Macr...

2025-11-15 08:00:00 ET Transcript Oscar Pulido: Welcome to The Bid, where we break down what's happening in the markets and explore the forces changing the economy and finance. I'm Oscar Pulido. Today we're bringing back our Ask Me Anything format, where I ask one of BlackRock's...

2025-11-13 05:41:00 ET By Tony DeSpirito Are U.S. stocks approaching bubble territory or is the bull run able to press on? Active investor Tony DeSpirito is optimistic but says pockets of bubble-like exuberance could create mispricings ― making it “an exciting ti...

2025-11-11 10:13:00 ET Healthcare stocks – oversold opportunity or a value trap? The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. This disconnect from fundamentals has cr...

2025-11-04 10:01:00 ET Transcript Jim Cramer: If you just do stocks like I see too many people, there's a good chance that you might lose it all.... Read the full article on Seeking Alpha For further details see: Jim Cramer On Investing - How To Make Money In Any...

2025-11-01 03:00:00 ET Innovation remains one of the most persistent drivers of long-term growth – reshaping industries, creating new markets, and sustaining momentum through economic cycles. Yet, identifying trends alone is no longer sufficient. Investors must recognize how them...

2025-10-24 10:56:43 ET Well, I am here again with my analysis of Gilead Sciences ( GILD ). Since my last article, "Gilead Sciences: HIV Leadership Outshines Decline in COVID-19 Drug Sales," was published on 9/2, Gilead shares have risen 8.8%, outperforming the S&P 500 ( SP...

2025-10-21 08:52:00 ET With the Fed walking a policy tightrope, investors should resist being complacent about risks and kicking the can down the road. There are opportunities across asset classes for those willing to be selective and carry a dose of caution as they assemble investmen...